Showing results (61-70 of 174) with videos related to
Sort By:
Pageof 18
Cancers|February 24, 2024
Infectious Complications in Patients with Myelodysplastic Syndromes: A Report from the Düsseldorf MDS RegistryAnnika Kasprzak, Julia Andresen, Kathrin Nachtkamp, et al.Haematologica|May 12, 2004
Levels of minimal residual disease detected by quantitative molecular monitoring herald relapse in patients with multiple myelomaRoland Fenk, Muharrem Ak, Guido Kobbe, et al.Transfusion|January 31, 2006
A single dose of 6 or 12 mg of pegfilgrastim for peripheral blood progenitor cell mobilization results in similar yields of CD34+ progenitors in patients with multiple myelomaIngmar Bruns, Ulrich Steidl, Ralf Kronenwett, et al.Haematologica|May 19, 2018
Transforming growth factor β1-mediated functional inhibition of mesenchymal stromal cells in myelodysplastic syndromes and acute myeloid leukemiaStefanie Geyh, Manuel Rodríguez-Paredes, Paul Jäger, et al.Journal of Translational Medicine|September 27, 2007
Monocyte derived dendritic cells generated by IFN-alpha acquire mature dendritic and natural killer cell properties as shown by gene expression analysisMark Korthals, Nancy Safaian, Ralf Kronenwett, et al.Neurology(R) Neuroimmunology & Neuroinflammation|December 17, 2024
Abatacept Induces Long-Term Reconstitution of the B-Cell Niche in a Patient With CTLA-4 Haploinsufficiency: A Case ReportSteffen Pfeuffer, Christopher Nelke, Marc Pawlitzki, et al.Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|May 14, 2018
Wilms' Tumor 1 Gene Expression Using a Standardized European LeukemiaNet-Certified Assay Compared to Other Methods for Detection of Minimal Residual Disease in Myelodysplastic Syndrome and Acute Myelogenous Leukemia after Allogeneic Blood Stem Cell TransplantationChristina Rautenberg, Sabrina Pechtel, Barbara Hildebrandt, et al.Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|October 4, 2011
Upfront allogeneic blood stem cell transplantation for patients with high-risk myelodysplastic syndrome or secondary acute myeloid leukemia using a FLAMSA-based high-dose sequential conditioning regimenChristian Saure, Thomas Schroeder, Fabian Zohren, et al.Annals of Hematology|August 6, 2018
Long-term outcome of high risk patients with myelodysplastic syndromes or secondary acute myeloid leukemia receiving intensive chemotherapyEsther Schuler, Natalie Zadrozny, Sabine Blum, et al.Digital Health|March 14, 2024
Application of wearables for remote monitoring of oncology patients: A scoping reviewKatharina Cloß, Marlo Verket, Dirk Müller-Wieland, et al.Pageof 18